Faculty of Dentistry of Dentistry Ainshams Univeristy
Cairo, Egypt
NCT Number: NCT06334770
Fourteen completely edentulous patients were selected to participate in this study. From the outpatient clinic of Prosthodontic Department, Faculty of Dentistry, Ain Shams University.
After fabrication of complete denture for all patients, patients were randomly divided to:
Group A: Seven patients were rehabilitated with implant retained maxillary overdenture where four Straumann BLX® implant were inserted opposed by mandibular complete denture.
Group B: Seven patients were rehabilitated with implant retained maxillary overdenture where four conventional acid etched implants were inserted opposed by mandibular complete denture.
After implant placement using surgical guide, smart peg and ostell device were used to measure the primary stability of the implant then cover screw was placed and after six weeks, secondary stability was measured for both groups.
After four months, the second stage started in which exposure of the implant fixtures took place and pick up was carried out.
Patients were recalled frequently for post-insertion inspection and adjustment.
Looking for future studies?
Notify Me45 year–60 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Background: long term success of implant restoration depends on many factors one of them is the sufficient implant stability which is lowered in compromised bone density sites such as the maxilla which is categorized as type III & IV bone, so searching for new innovation and updates in implant material and features is very mandatory. So, the aim of this study was asses and compare between two implant materials roxolid versus traditional titanium on the primary and secondary stability.
Methods: eighteen completely edentulous patients were selected they all received maxillary implant retained overdentures and lower complete dentures, they were divided equally in to two groups according to the type of the material of the implants. Group A received a total number of 36 (Roxolid) Implants were made of roxolid material and Group B received a total number 36 (Titanium) implants were made of traditional titanium alloys. Implant stability was assed using ostell device, the primary implant stability was measured at the day of implant installation however, secondary implant stability was measured after six weeks of implant placement. Paired t-test was used to compare between primary and secondary stability in the same group and independent t-test was used to compare between the two groups with a significant level < 0.05.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
four Straumann BLX® roxolid implant 15% zirconium and 85% titanium), 3.7 mm in diameter, and 10 mm in length.implants were selected with the following criteria: tapered, self-tapping, aggressively threaded,were inserted with novalock attachments.
Other names: Straumann BLX® SLA implants
four conventional acid etched pure implants tapered, self-tapping, threaded, two-piece, with the 10 mm length and 3.7 mm diameter were inserted with Sphero flex attachments.
Other names: JD EVOLUTION PLUS implants
Time frame: same day of implant placement
using an Ostell device with a smart peg to measure primary stability at the time of implant placement and measuring secondary stability after six weeks of implant placement.
Time frame: 6 weeks
measuring secondary stability using ostell device and smart peg
Ain Shams University
Other
Influence of Roxolid Implant Material on the Implant Stability of Maxillary Implant Retained Overdenture
Acronym: BLX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05585008
Completely Edentulous Patients
Bilbeis, Sharqia Province, Egypt
View Trial DetailsNCT04694209
Completely Edentulous Patients
Cairo, Manial, Egypt
View Trial DetailsNCT06755034
Completely Edentulous Patients
Geneva, Canton of Geneva, Switzerland
View Trial Details